Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004293067 | SCV003952621 | uncertain significance | not specified | 2023-03-29 | criteria provided, single submitter | clinical testing | The c.688G>A (p.V230M) alteration is located in exon 6 (coding exon 6) of the UBA7 gene. This alteration results from a G to A substitution at nucleotide position 688, causing the valine (V) at amino acid position 230 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003928972 | SCV004742468 | likely benign | UBA7-related disorder | 2023-04-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |